Latest Cancer News

FDA Grants Breakthrough Therapy Designation to AP26113 for ALK-Positive NSCLC (10-22-2014)
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to an investigational agent AP26113 for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small... Continue Reading

Adding Cediranib to Olaparib Markedly Improves Progression-Free Survival but Increases Toxicity in Recurrent Platinum-Sensitive Ovarian Cancer (10-21-2014)
The addition of the antiangiogenic agent cediranib to the PARP inhibitor olaparib in women with recurrent platinum-sensitive ovarian cancer improves time to cancer progression and survival. The results... Continue Reading

Second-line Avastin Improves Progression-Free Survival in Advanced HER2-Negative Breast Cancer (10-20-2014)
Adding Avastin® (bevacizumab) to chemotherapy in second-line treatment of advanced HER2-negative breast cancer improves progression-free survival. Results of the phase III TANIA trial evaluating the role... Continue Reading

More Cancer News

Locations

VIRGINIA BEACH OFFICE
1200 First Colonial Road
Suite 204
Virginia Beach, VA 23454
Phone (757)363-8212
Fax (757)363-2246
View Map

CHESAPEAKE OFFICE
Chesapeake Medical Center
110 Wimbledon Square
Suite E
Chesapeake, VA 23320
Phone (757)436-2995
Fax (757)436-2912
View Map

SUFFOLK OFFICE
Cancer Specialists of Tidewater
5835 Harbour View Blvd.
Suite C
Suffolk, VA 23435
Phone (757)397-4200
Fax (757)397-3872
View Map